Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study

BACKGROUND: Tenofovir alafenamide (TAF) has good viral suppression efficacy and less adverse effect than tenofovir disoproxil fumarate (TDF). Real-world studies on the antiviral efficacy and safety of switching from TDF to TAF in patients with chronic hepatitis B (CHB) are limited. METHODS: This ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Pei-Yuan, Su, Wei-Wen, Hsu, Yu-Chun, Huang, Siou-Ping, Yen, Hsu-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Drugs and Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607928/
https://www.ncbi.nlm.nih.gov/pubmed/34820208
http://dx.doi.org/10.7717/peerj.12527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607928/
https://www.ncbi.nlm.nih.gov/pubmed/34820208
http://dx.doi.org/10.7717/peerj.12527

Ejemplares similares